- Home
- BSET vs TSVT Comparison
BSET vs TSVT Comparison
Compare BSET & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSET
- TSVT
- Stock Information
- Founded
- BSET 1902
- TSVT 2021
- Country
- BSET United States
- TSVT United States
- Employees
- BSET N/A
- TSVT N/A
- Industry
- BSET Home Furnishings
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- BSET Consumer Discretionary
- TSVT Health Care
- Exchange
- BSET Nasdaq
- TSVT Nasdaq
- Market Cap
- BSET 134.7M
- TSVT 128.5M
- IPO Year
- BSET 1987
- TSVT N/A
- Fundamental
- Price
- BSET $14.38
- TSVT $2.48
- Analyst Decision
- BSET
- TSVT Buy
- Analyst Count
- BSET 0
- TSVT 6
- Target Price
- BSET N/A
- TSVT $10.40
- AVG Volume (30 Days)
- BSET 10.6K
- TSVT 449.7K
- Earning Date
- BSET 01-31-2025
- TSVT 03-04-2025
- Dividend Yield
- BSET 5.69%
- TSVT N/A
- EPS Growth
- BSET N/A
- TSVT N/A
- EPS
- BSET N/A
- TSVT N/A
- Revenue
- BSET $340,285,000.00
- TSVT $45,620,000.00
- Revenue This Year
- BSET N/A
- TSVT N/A
- Revenue Next Year
- BSET $1.77
- TSVT $36.09
- P/E Ratio
- BSET N/A
- TSVT N/A
- Revenue Growth
- BSET N/A
- TSVT N/A
- 52 Week Low
- BSET $12.11
- TSVT $2.35
- 52 Week High
- BSET $16.50
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- BSET 56.27
- TSVT 35.00
- Support Level
- BSET $13.66
- TSVT $2.36
- Resistance Level
- BSET $14.47
- TSVT $2.53
- Average True Range (ATR)
- BSET 0.30
- TSVT 0.18
- MACD
- BSET 0.06
- TSVT 0.01
- Stochastic Oscillator
- BSET 89.27
- TSVT 13.82
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.